Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer.
Saved in:
| Title: | Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer. |
|---|---|
| Authors: | Moore KN; University of Oklahoma Health Sciences Center, Oklahoma City, OK, United States of America; Sarah Cannon Research Institute, Nashville, TN, United States of America. Electronic address: Kathleen-Moore@ouhsc.edu., Birrer MJ; University of Alabama, Birmingham, AL, United States of America., Marsters J; Genentech, Inc., South San Francisco, CA, United States of America., Wang Y; Genentech, Inc., South San Francisco, CA, United States of America., Choi Y; Genentech, Inc., South San Francisco, CA, United States of America., Royer-Joo S; Genentech, Inc., South San Francisco, CA, United States of America., Lemahieu V; Genentech, Inc., South San Francisco, CA, United States of America., Armstrong K; Genentech, Inc., South San Francisco, CA, United States of America., Cordova J; Genentech, Inc., South San Francisco, CA, United States of America., Samineni D; Genentech, Inc., South San Francisco, CA, United States of America., Schuth E; Genentech, Inc., South San Francisco, CA, United States of America., Vaze A; Genentech, Inc., South San Francisco, CA, United States of America., Maslyar D; Genentech, Inc., South San Francisco, CA, United States of America., Humke EW; Genentech, Inc., South San Francisco, CA, United States of America., Hamilton EP; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, United States of America., Liu JF; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States of America. |
| Source: | Gynecologic oncology [Gynecol Oncol] 2020 Sep; Vol. 158 (3), pp. 631-639. Date of Electronic Publication: 2020 Jun 11. |
| Publication Type: | Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Academic Press Country of Publication: United States NLM ID: 0365304 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1095-6859 (Electronic) Linking ISSN: 00908258 NLM ISO Abbreviation: Gynecol Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
